Delivery Order HHSN261201000048I-HHSN26100001
Award Date
7/20/10
Potential Completion Date
3/31/15
Potential Value
$235K
Federal Agency
National Cancer Institute
Awardee
Henry Ford Health System
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Detroit, MI 48202, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $23,563,700.00 delivery order contract awarded to Henry Ford Health System by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract is a task order under the larger "Cancer Study Cohort Recruitment" Indefinite Delivery, Indefinite Quantity (IDIQ) master agreement. The contract has no set-aside designation. Under this task order, Henry Ford Health System will provide services related to the CONNECT initiative,...
This is a delivery order contract awarded by the National Cancer Institute, a civilian federal agency, to Henry Ford Health System, a non-profit integrated healthcare provider and research organization. The contract, valued at $857,850.52, is for continued infrastructure setup and is part of a larger indefinite delivery, indefinite quantity (IDIQ) master agreement focused on cancer study cohort recruitment. The contract does not have a set-aside designation. Through this task order, Henry Ford...
This is a $866,368.00 delivery order awarded by the National Institutes of Health (NIH) National Cancer Institute to Henry Ford Health System, a non-profit health care organization based in Detroit, Michigan. The contract is for the setup and recruitment of participants for a cancer study cohort in Detroit over a five-year period. This delivery order is part of a larger Cancer Study Cohort Recruitment master contract vehicle with NIH. The contract does not have a set-aside designation. As a...
This is a task order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Henry Ford Health System, a non-profit integrated healthcare provider located in Detroit, Michigan, to prepare for and conduct a cancer study cohort recruitment. The task order, which has a potential value of $20,054,873.00, was awarded on August 1, 2020 and is scheduled for completion on June 30, 2025. The task order was issued under a larger...
This $53,000.00 firm fixed price purchase order contract was awarded by a U.S. government agency to Henry Ford Health System, a non-profit integrated health care provider organization based in Detroit, Michigan. The contract is for a "MULTIPLEX ANCILLARY STUDY TO PAY FOR SUBJECT REIMBURSEMENT" and was completed on December 31, 2008. There was no set-aside designation used for this award. Based on Henry Ford Health System's experience as a prime contractor and subcontractor for...
This is a firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute, part of the National Institutes of Health (NIH), to Henry Ford Health System to provide support services for the LAMPOON Protocol Investigational Device Exemption (IDE) Enrollment Sites. The contract has a ceiling value of $96,000.00 and a performance period ending on June 18, 2022. The contract does not have a set-aside designation. Henry Ford Health System, a major non-profit integrated...
This is a firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, to Henry Ford Health System, a non-profit healthcare provider and research organization in Detroit, Michigan. The contract is for $87,000.26 to provide Computed Tomography (CT) and Echocardiography (ECHO) analysis services in support of the Lampoon Protocol, with a performance period ending on July 2, 2020. This contract does...
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) in the amount of $201,998.50. The contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase, an indefinite delivery contract. The contract is for the recovery and provision of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is part of the...
This is a delivery order issued under the National Cancer Institute's Cancer Genome Atlas Program Tissue Purchase contract. The $388,593.75 firm fixed-price award to the Regents of the University of Michigan was made to provide tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The award was funded through the American Recovery and Reinvestment Act (ARRA) and has a performance period ending on March 31, 2015. No set-aside designation was used for...
This is a $884,040.57 firm fixed price delivery order contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract is for the acquisition of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. The contract was awarded to Indivumed, Inc., a for-profit organization, and is not set aside for any special designation. The contract is a delivery order under the NCI Cancer...